Results 101 to 110 of about 6,709 (216)

Epidemiological insights and clinical management of paediatric kala-azar in Shanxi Province (2014-2023): retrospective analysis of case characteristics and therapeutic strategies. [PDF]

BMJ Paediatr Open
Zhao J, Ullah I, Fan H, Li X.
europepmc   +1 more source

Histological findings associated with treatment response in cutaneous leishmaniasis: a clinicopathological correlation study. [PDF]

Int J Dermatol, 2023
Riyal H, Samaranayake N, Amarathunga P, Munidasa D, Karunaweera ND.   +4 more
europepmc   +1 more source

Identification of CβS and ODC antimony resistance markers in anthroponotic cutaneous leishmaniasis field isolates by gene expression profiling. [PDF]

Parasite Epidemiol Control
Zarrinkar F, Sharifi I, Tavakoli Oliaee R, Afgar A, Molaakbari E, Bamorovat M, Babaei Z, Eskandari E, Salarkia E, Asadi M.   +9 more
europepmc   +1 more source

Healing effects of autologous platelet gel and growth factors on cutaneous leishmaniasis wounds in addition to antimony; a self-controlled clinical trial with randomized lesion assignment. [PDF]

BMC Res Notes, 2023
Shadmand E, Solhjoo K, Taghipour A, Tayer AH, Sadeghi F, Meshkin A.   +5 more
europepmc   +1 more source

Comparison of Intralesional Sodium Stibogluconate versus Intralesional Meglumine Antimoniate for the Treatment of Leishmania major Cutaneous Leishmaniasis. [PDF]

Acta Derm Venereol
Solomon M, Ollech A, Pavlotsky F, Barzilai A, Schwartz E, Baum S, Astman N.   +6 more
europepmc   +1 more source

Chronic ulceration as a late manifestation of tropical disease. [PDF]

Postepy Dermatol Alergol
Janocha-Litwin J, Marczuk J, Węgłowska J, Simon K.   +3 more
europepmc   +1 more source

Progress in antileishmanial drugs: Mechanisms, challenges, and prospects. [PDF]

PLoS Negl Trop Dis
Zhang H, Yan R, Liu Y, Yu M, He Z, Xiao J, Li K, Liu G, Ning Q, Li Y.   +9 more
europepmc   +1 more source

A Preliminary Note on the Treatment of 21 Cases of Kala-Azar with Sodium Antimony Gluconate. (With Special Reference to Its Suitability for Mass Administration on Tea Estates).

, 1944
Edmund C. Burke, Kuntal Chakravarty
openalex   +1 more source

Unravelling drug resistance in leishmaniasis: genomic adaptations and emerging therapies. [PDF]

Front Mol Biosci
Bhusal CK, Sinha S, Kaur D, Sehgal R.
europepmc   +1 more source

Stibanate (sodium antimony gluconate) with pedunculine in the treatment of kalaazar.

, 1947
Sanyal Sc
openalex   +1 more source